NF110: Open-label, Phase 2 Clinical Trial of Crizotinib for Children and Adults with Neurofribromatosis Type 2 and Progressive Vestibular Schwannomas
NOT ENROLLING
Trial ID:
NCT04283669 Protocol # :
20-672
Phase
II
Disease Sites
Brain and Nervous System
Principal Investigator
Ullrich, Nicole
Site Research Nurses
Aste, Marie, Francesca
Hibyan, Lauren, M.
Strachan, Marylynne
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #20-672
20-672